Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Vasomotor symptoms (all doses) · postmenopausal women with vasomotor symptoms

Tibolone probably leads to lower vasomotor symptoms (all doses) compared with placebo (moderate certainty).

1 finding from 1 review

Short‐term and long‐term effects of tibolone in postmenopausal women 2016 · Cochrane Headline outcomes only
OR 0.33 [0.27, 0.41]
5 studies · 842 participants
Moderate